🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

4 recruiting trials

for Lipoprotein Lipase Deficiency

CS-121 APOC3 Base Editing in FCS NCT07176923EARLY Phase 11 site📍 Hefei CorrectSequence Therapeutics Co., Ltd · Tests: CS-121 A Study of Olezarsen for the Treatment of Familial Chylomicronemia Syndrome (FCS) in Pediatric Participants NCT07727538Phase 35 sites📍 Birmingham📍 San Francisco📍 Dallas Ionis Pharmaceuticals, Inc. · Tests: Olezarsen CS-121 APOC3 Base Editing in Children and Adolescents With Hyperchylomicronemia NCT07371767EARLY Phase 11 site📍 Shanghai Shanghai Jiao Tong University School of Medicine · Tests: CS-121 Postprandial Fatty Acid Metabolism in Subjects With Lipoprotein Lipase Deficiency NCT04227678NA1 site📍 Sherbrooke Université de Sherbrooke · Tests: Heparin, liquid meal
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy